Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Repurchased during the quarter as macro uncertainty drove the name down into the midcap capitalization range, presenting an attractive entry point.
— John W. Rogers
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on The Goldman Sachs Group, Inc.
Goldman Sachs achieved a strong quarterly earnings beat driven by positive performance across banking, trading, and asset management. The manager expects...
Goldman Sachs posted solid earnings driven by strong financing activity and improved advisory revenue despite lower investment banking transaction volumes. The firm is...
More institutional theses from Ariel Appreciation Fund
OneSpaWorld Holdings ($OSW), holding a 2.6% position in the portfolio, is the dominant global provider of outsourced health, wellness, and spa services onboard luxury cruise vessels and destination resorts. The manager maintains...
Charles River Laboratories ($CRL), which represents 3.9% of the fund's portfolio, is an essential contract research organization providing discovery and safety assessment services, laboratory products, and manufacturing support to the global biopharmaceutical industry. The manager holds...
Haemonetics Corporation ($HAE), constituting 2.7% of the fund, develops and distributes specialized hematology technologies, blood management products, and plasma collection solutions. The manager is...